Evidence map›Paper›PMID 27481954›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

Patient-Reported Outcome Assessments as Endpoints in Studies in Infectious Diseases.

John H Powers, Kellee Howard, Todd Saretsky, Sarah Clifford, Steve Hoffmann, Lily Llorens, George Talbot

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
11.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Proxy- and Patient-Reported Outcome Measures in Cleft Lip and/or Palate Under 8 Years of Age: A Scoping Review.The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association · 2026
    Article
  3. Patient-Reported Outcomes and Health-Related Quality-of-Life Measures in Infectious Diseases Studies and Clinical Practice.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Desirability of outcome ranking and quality life measurement for antimicrobial research in organ transplantation.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Review
  12. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

John H PowersGeorge Washington University School of Medicine.
Kellee HowardICON PLC, San Francisco, California.
Todd SaretskyICON PLC, San Francisco, California.
Sarah CliffordICON PLC, San Francisco, California.
Steve HoffmannFoundation for the National Institutes of Health, Bethesda, Maryland.
Lily LlorensLlorens Consulting, Bay Village, Ohio.
George TalbotTalbot Advisors, LLC, Anna Maria, Florida.
Foundation for the National Institutes of Health · USGeorge Washington University · USHealthcentric Advisors · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The goal of administering medical interventions is to help patients live longer or live better. In keeping with this goal, there has been increasing interest in taking the "voice" of the patient into account during the development process, specifically in the evaluation of treatment benefits of medical interventions, and use of patient-centered outcome data to justify reimbursement. Patient-reported outcomes (PROs) are outcome assessments (OAs) used to define endpoints that can provide direct evidence of treatment benefit on how patients feel or function. When PROs are appropriately developed, they can increase the efficiency and clinical relevance of clinical trials. Several PROs have been developed for OA in specific infectious diseases indications, and more are under development. PROs also hold promise for use in evaluating adherence, adverse effects, satisfaction with care, and routine clinical practice.

Indexed as

Clinical Trials as TopicPatient Outcome AssessmentAnti-Bacterial AgentsCommunicable DiseasesHumansPractice Guidelines as TopicAnti-Bacterial Agentsclinical practiceclinical trialsendpointsinfectious diseasespatient-reported outcomes

Identifiers

PMID27481954
PMCPMC5006216
OpenAlexW2494153709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.